Infertility is a disease of the
reproductive system. One third (30%) of infertility can be attributed to
male factors, and about one third (30%) can be attributed to female
factors. In about 20% of cases infertility is unexplained, and the
remaining 10% of infertility is caused by a combination of problems in both
partners.
Infertility is defined as the
inability to conceive or carry a pregnancy to term after 12 months of trying to
conceive. If you are over the age of 35, the time of trying to conceive
is reduced to 6 months. It is important to see a specialist, or a
Reproductive Endocrinologist, or in some cases your OB/Gyn or urologist for a
complete fertility work-up and diagnosis.
Sperm Health: What Men Need to Know
- Sperm Count:
It is critical for men to have a healthy sperm count for optimal fertility. Men with at least 15 million sperm per milliliter are well within a normal, healthy sperm count. The average human ejaculate contains about 180 million sperm (66 million/ml), but some ejaculates contain as many as 400 million sperm.
- Morphology: (appearance)
A healthy sperm has an oval head and long tail, allowing for the sperm to be propelled forward effectively. When a sperm has a small, large, misshapen, crooked or tapered head, its ability to fertilize an egg is decreased. Sperm with tails that are doubled, curled or kinky are also unlikely to fertilize an egg. Fertile men have a normal shape and structure to 14 percent of their sperm, but at least four percent is thought to be the lower limit of fertilizing capacity.
- Motility: (movement)
The ability of a sperm to propel itself and move forward is imperative to successful conception. Sperm that are immobile, slow or have inhibited motility due to morphology abnormalities are unable to reach the egg for fertilization. Fertile men have 40 percent or more of their sperm exhibiting healthy motility.
Men with a lower sperm count, low morphology or low motility may need the assistance of reproductive endocrinologists to optimize fertility odds. This can be accomplished through a variety of infertility treatment methods such as methods such as semen processing for intrauterine insemination and In Vitro Fertilization using ICSI (the injection of a sperm into an egg.)
LUTEAL PHASE DEFECT (LPD)
The menstrual cycle has two roughly equal parts that are divided by ovulation. The first (preovulatory) is the proliferative (follicular) phase which is characterized by the growth and development of at least one “dominant” ovarian follicle that produces the hormone estrogen that promotes growth and development of the uterine lining (endometrium). The second is the the secretory (luteal) phase. It commences with the release of one or more eggs by the dominant follicle(s) and is characterized by the conversion of the ruptured dominant follicle into a “yellow structure” known as the corpus luteum (CL). In addition to estrogen, the CL produces progesterone hormones which causes the endometrial gland to produce secretions that are intended to nurture the early implanting embryo as it sends its root system (trophoblast) into the uterine lining as it strives to makes contact with the mother’s blood system.
In regularly ovulating women, the menstrual cycle is usually quite regular in length, ranging from 26-32days. However, this can vary somewhat and when it does, it is usually the proliferative (follicular) phase that is shortened or lengthened. The secretory (luteal) phase is usually quite constant and regular in duration, rarely varying by more than a day or two in length. The role of CL hormones is to prepare the uterine lining to accept and support the implanting embryo during the first 8 weeks of pregnancy whereupon the embryo’s “root system” (that ultimately develops into the placenta), takes over hormone production completely from the ovary. In fact, by the 9th to 10th week, even were both ovaries to be surgically removed, the pregnancy would continue to develop autonomously. This also serves to explain why in embryo recipient cycles (frozen embryo transfers, egg donor IVF etc.), where hormones must be administered because the ovaries do not contribute hormones to the developing embryo, hormone supplementation can be discontinued after the 10th week of pregnancy.
The life span of the CL determines the length of the secretory (luteal) phase. It survives for 12-13 days, unless rescued by the early release of hCG from the implanting embryo. If no implantation occurs, the CL stops making estrogen and progesterone, and menses will usually ensue 1-3 days later.
As stated above, for most women, the length of the second half of the menstrual cycle is constant at 13-14 days. In a small percentage of infertile women (3-5%), hormone production by the CL is compromised and/or the length of the secretory (luteal) phase is shortened by more than 3 or 4 days. This often results in inadequate endometrial secretory development – referred to as a luteal phase defect (LPD). In some cases, this prevents embryo attachment altogether (resulting in “infertility”) while in other cases it can result in early miscarriage due to insufficient hormonal support for the “budding” pregnancy.
The lining of the uterus has a specific appearance that changes throughout the menstrual cycle. Because of this fact, a biopsy of the lining a few days prior to expected menstruation can accurately date endometrial development and hence the potential of the secretory endometrium to support implantation. A difference of more than 3 days between endometrial dating by biopsy and dating by cycle day (as determined by the start of the preceding menstrual period) is highly suggestive of a luteal phase defect (LPD). In addition, a blood progesterone level of less than 10ng/dl a week after ovulation can also be used to diagnose a LPD.
In the past, LPDs were traditionally treated through progesterone administration in the secretory (luteal) phase of the cycle and continued though the first 12 weeks of pregnancy (the 1st trimester). However, since all LPDs begin with a poor proliferative (follicular) phase and inadequate dominant follicle development, it follows that such an approach represents an over-simplification of the problem. What is needed is reinstitution of normal follicular development with ovulation induction using oral fertility drugs such as clomiphene and Letrozol, or injectable gonadotropins such as Menopur, Follistim or Gonal F, followed by hCG to trigger ovulation. Thereupon, progesterone or hCG supplementation can be added until the 8th-9th week of pregnancy.
Sadly, the diagnosis of LPD is often missed. This is yet another example of where the term “unexplained infertility or miscarriage” should be supplanted by “undiagnosed reproductive failure.”
“So I’m someone’s mom!” Welcoming our first child, Cecily Philips Donnell, at 12:24 p.m. on Tuesday, July 14. We are absolutely head over heels in love with Cecily, and parenthood is already the most insane and beautiful thing in existence, It's made me excited to have a little spitfire of a daughter of my own. I remembered when i found out i was pregnant 3years ago and was about to walk away from the musical. But at eight weeks, i had a miscarriage. i was so unhappy, until i seek help spiritually from a Dr Iya the herbal practitioner, who helps and guide me to get pregnant again, even at the trying times few weeks in April when i battled symptoms of the coronavirus including "a cough that makes it feel like my head is splitting open from the inside out, but luckily, the baby was okay with the doctors help. i am happy to finally be a mother, couples out there that needs help, trying to conceive a baby, contact my doctor on nativeiyabasira@yahoo.com , you will definitely have a baby to make you a parent.
ReplyDelete